Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-10314-9, published online 19 April 2022
The original version of this Article contained errors in Tables 2 and 3. Under the heading ‘Resistant’, the values in the column ‘%age’ were a duplicate of the values in the column ‘proportion’. The correct and incorrect values appear below.
Incorrect Table 2:
Antimicrobials | Resistant |
---|---|
%age | |
Colistin | 0.00 |
Meropenem | 0.50 |
Gentamicin | 0.54 |
Amikacin | 0.55 |
Cefoperazone-sulbactam | 0.57 |
Imipenem | 0.53 |
Piperacillin-tazobactam | 0.57 |
Levofloxacin | 0.77 |
Ciprofloxacin | 0.72 |
Ampicillin-sulbactam | 0.85 |
Cefepime | 0.71 |
Amoxicillin-clavulanic acid | 0.57 |
Ceftazidime | 0.62 |
Correct Table 2:
Antimicrobials | Resistant |
---|---|
%age | |
Colistin | 0 |
Meropenem | 50 |
Gentamicin | 54 |
Amikacin | 55 |
Cefoperazone-sulbactam | 57 |
Imipenem | 53 |
Piperacillin-tazobactam | 57 |
Levofloxacin | 77 |
Ciprofloxacin | 72 |
Ampicillin-sulbactam | 85 |
Cefepime | 71 |
Amoxicillin-clavulanic acid | 57 |
Ceftazidime | 62 |
Incorrect Table 3:
Antimicrobials | Resistant |
---|---|
%age | |
Colistin | 0.00 |
Amikacin | 0.52 |
Gentamicin | 0.68 |
Cefoperazone-sulbactam | 0.68 |
Meropenem | 0.70 |
Imipenem | 0.72 |
Piperacillin-tazobactam | 0.76 |
Levofloxacin | 0.82 |
Ciprofloxacin | 0.82 |
Ampicillin-sulbactam | 0.85 |
Cefepime | 0.86 |
Aztreonam | 0.92 |
Amoxicillin-clavulanic acid | 0.96 |
Correct Table 3:
Antimicrobials | Resistant |
---|---|
%age | |
Colistin | 0 |
Amikacin | 52 |
Gentamicin | 68 |
Cefoperazone-sulbactam | 68 |
Meropenem | 70 |
Imipenem | 72 |
Piperacillin-tazobactam | 76 |
Levofloxacin | 82 |
Ciprofloxacin | 82 |
Ampicillin-sulbactam | 85 |
Cefepime | 86 |
Aztreonam | 92 |
Amoxicillin-clavulanic acid | 96 |
Additionally, in Table 4, under ‘P. aeruginosa’, ‘Colistin-dHAM (%age)’, the values for ‘aComparison between and within groups (7th day), p value = 0.000*’ and ‘Comparison between and within groups (14th day), p value = 0.012*’ were interchanged. The correct and incorrect values appear below.
Incorrect Table 4:
Days | Statistical measures | Treatment groups (zones of inhibition in mm) |
---|---|---|
Colistin-dHAM (%age) | ||
P. aeruginosa | ||
aComparison between and within groups (7th day), p value = 0.000* | ||
7th day | Mean ± SD b(p values) | 36.0 ± 6.1 (p: 0.001*) |
Comparison between and within groups (14th day), p value = 0.012* | ||
14th day | Mean ± SD (p values) | 32.3 ± 11.0 (p: 0.014*) |
Correct Table 4:
Days | Statistical measures | Treatment groups (zones of inhibition in mm) |
---|---|---|
Colistin-dHAM (%age) | ||
P. aeruginosa | ||
aComparison between and within groups (7th day), p value = 0.000* | ||
7th day | Mean ± SD b(p values) | 32.3 ± 11.0 (p: 0.014*) |
Comparison between and within groups (14th day), p value = 0.012* | ||
14th day | Mean ± SD (p values) | 36.0 ± 6.1 (p: 0.001*) |
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wali, N., Shabbir, A., Wajid, N. et al. Author Correction: Synergistic efficacy of colistin and silver nanoparticles impregnated human amniotic membrane in a burn wound infected rat model. Sci Rep 12, 15373 (2022). https://doi.org/10.1038/s41598-022-20203-w
Published:
DOI: https://doi.org/10.1038/s41598-022-20203-w